Inhibition of pancreatic cancer cell growth and induction of apoptosis with novel therapies directed against protein kinase A

Surgery

Volumn 134, Issue 2, 2003, Pages 197-205

  Farrow, Buckminster ^b   Rychahou, Piotr ^b   Murillo, Carlos ^b   O'Connor, Kathleen L ^b   Iwamura, Takeshi ^b   Evers, B Mark ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; ISOBUTYLMETHYLXANTHINE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROTEIN; PROTEIN RIALPHA; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INHIBITION; CELL STRAIN; CELL STRAIN MIA PACA 2; CELL STRAIN PANC 1; CELL STRAIN SUIT 2; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG SCREENING; DRUG TARGETING; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; TREATMENT PLANNING;

EID: 0042328100     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2003.220     Document Type: Article

References (25)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
2. Lillemoe KD, Yeo CJ, Cameron JL. Pancreatic cancer: state-of-the-art care. CA Cancer J Clin 2000;50:241-68.
3. Yeo CJ, Abrams RA, Grochow LB, Sohn TA, Ord SE, Hruban RH, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience. Ann Surg 1997;225:621-36.
4. Cho-Chung YS, Pepe S, Clair T, Budillon A, Nesterova M. cAMP-dependent protein kinase: role in normal and malignant growth. Crit Rev Oncol Hematol 1995;21:33-61.
5. Krebs EG. Protein kinases. Curr Top Cell Regul 1972;5:99-133.
6. McDaid HM, Cairns MT, Atkinson RJ, McAleer S, Harkin DP, Gilmore P, et al. Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer. Br J Cancer 1999;79:933-9.
7. Young MR, Montpetit M, Lozano Y, Djordjevic A, Devata S, Matthews JP, et al. Regulation of Lewis lung carcinoma invasion and metastasis by protein kinase A. Int J Cancer 1995;61:104-9.
8. Bradbury AW, Carter DC, Miller WR, Cho-Chung YS, Clair T. Protein kinase A (PK-A) regulatory subunit expression in colorectal cancer and related mucosa. Br J Cancer 1994;69:738-42.
9. Tortora G, Ciardiello F. Protein kinase A as target for novel integrated strategies of cancer therapy. Ann NY Acad Sci 2002;968:139-47.
10. Tortora G, Ciardiello F. Targeting of epidermal growth factor receptor and protein kinase A: molecular basis and therapeutic applications. Ann Oncol 2000;11:777-83.
11. Wang H, Cai Q, Zeng X, Yu D, Agrawal S, Zhang R. Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIalpha subunit of protein kinase A after oral administration. Proc Natl Acad Sci U S A 1999;96:13989-94.
12. McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, Kay MA. RNA interference in adult mice. Nature 2002;418:38-9.
13. Wang Q, Li N, Wang X, Kim MM, Evers BM. Augmentation of sodium butyrate-induced apoptosis by phosphatidylinositol 3′-kinase inhibition in the KM20 human colon cancer cell line. Clin Cancer Res 2002;8:1940-7.
14. Hernandez A, Thomas R, Smith F, Sandberg J, Kim S, Chung DH, et al. Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis. Surgery 2001;130:265-72.
15. Wang Q, Ding Q, Dong Z, Ehlers RA, Evers BM. Downregulation of mitogen-activated protein kinases in human colon cancers. Anticancer Res 2000;20:75-83.
16. O'Connor KL, Mercurio AM. Protein kinase A regulates Rac and is required for the growth factor-stimulated migration of carcinoma cells. J Biol Chem 2001;276:47895-900.
17. Choi BM, Park R, Pae HO, Yoo JC, Kim YC, Jun CD, et al. Cyclic adenosine monophosphate inhibits ursolic acid-induced apoptosis via activation of protein kinase A in human leukaemic HL-60 cells. Pharmacol Toxicol 2000;86:53-8.
18. Kim SN, Ahn YH, Kim SG, Park SD, Cho-Chung YS, Hong SH. 8-Cl-cAMP induces cell cycle-specific apoptosis in human cancer cells. Int J Cancer 2001;93:33-41.
19. Qin Y, Ertl T, Groot K, Horvath J, Cai RZ, Schally AV. Somatostatin analog RC-160 inhibits growth of CFPAC-1 human pancreatic cancer cells in vitro and intracellular production of cyclic adenosine monophosphate. Int J Cancer 1995;60:694-700.
20. Liu CD, Slice LW, Balasubramaniam A, Walsh JH, Newton TR, Saxton RE, et al. Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphate levels. Surgery 1995;118:229-36.
21. Boucher MJ, Duchesne C, Laine J, Morisset J, Rivard N. cAMP protection of pancreatic cancer cells against apoptosis induced by ERK inhibition. Biochem Biophys Res Commun 2001;285:207-16.
22. Nesterova M, Noguchi K, Park YG, Lee YN, Cho-Chung YS. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed downregulation of protein kinase A RIalpha protein. Clin Cancer Res 2000;6:3434-41.
23. Bold RJ, Warren RE, Ishizuka J, Cho-Chung YS, Townsend CM Jr, Thompson JC. Experimental gene therapy of human colon cancer. Surgery 1994;116:189-96.
24. Elbashir SM, Harborth J, Weber K, Tuschl T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 2002;26:199-213.
25. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002;419:624-9.